Mark Epstein MD, MBA
About Mark Epstein MD, MBA
Mark Epstein, MD, MBA, serves as the Chief Medical Officer at RS21 and has extensive experience in healthcare management, finance, and policy development. He has held various leadership roles in healthcare organizations, including positions at True Health New Mexico and Presbyterian Healthcare Services.
Current Role at RS21
Mark Epstein serves as the Chief Medical Officer at RS21 since 2023. In this role, he is responsible for overseeing medical operations and ensuring the integration of clinical insights into the company's strategies. His leadership aims to enhance the effectiveness of healthcare solutions provided by RS21.
Previous Experience in Emergency Medicine
Mark Epstein has a background in emergency medicine, having worked as a Consultant at Taranaki District Health Board in New Zealand from 2004 to 2005. He also completed his Emergency Medicine Residency Program at The University of New Mexico from 1992 to 1995, which provided him with foundational skills in emergency care.
Leadership Roles in Healthcare Organizations
Mark Epstein has held several leadership positions in healthcare organizations. He was the Chief Medical Officer at New Mexico Health Connections from 2012 to 2017 and served as Medical Director at Presbyterian Healthcare Services in various capacities from 2006 to 2012. His roles involved optimizing operational efficiencies and enhancing patient care services.
Education and Professional Development
Mark Epstein earned his MD from Yale University School of Medicine, completing his studies from 1987 to 1992. He also achieved an MBA from the Haslam College of Business at the University of Tennessee in 2007. Additionally, he holds a Bachelor's degree in Human Biology (Neuropsychology) from Stanford University, which he completed from 1982 to 1986.
Involvement in Healthcare Startups
Since 2019, Mark Epstein has been actively involved as an advisor, investor, and board member for multiple companies in the healthcare startup space. His expertise in managed care and healthcare finance allows him to provide strategic guidance and investment insights to emerging healthcare ventures.